Risk of Development of Resistance in Patients with Non-Cystic Fibrosis Bronchiectasis Treated with Inhaled Antibiotics

Current Pulmonology Reports
Kate H Regan, Adam T Hill

Abstract

Bronchiectasis is a debilitating chronic lung disease characterised by recurrent bacterial infection and colonisation with significant associated morbidity and mortality. To date, there are few licenced treatments, and the mainstay of clinical management is prompt antibiotic therapy for exacerbations and regular airway clearance. Inhaled antibiotics are a potential long-term treatment for those with recurrent exacerbations, and represent an obvious advantage over other routes of administration as they achieve high concentrations at the site of infection whilst minimising systemic side effects. The main caveat to such treatment is the development of antimicrobial resistance due to altered selection pressures. Numerous studies of various inhaled antimicrobials have demonstrated favourable safety and efficacy profiles for bronchiectasis patients with chronic infection, which are supportive of their use in clinical practice. There is no convincing evidence of treatment-emergent pathogens or pathogens developing resistance to the inhaled antibiotic therapy.

References

Aug 1, 1997·The European Respiratory Journal·C B WilsonR Wilson
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·C B WilsonR Wilson
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·N R Crowther LabirisM T Newhouse
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·A F BarkerJ Quan
Mar 14, 2002·Seminars in Respiratory Infections·Sujatha Rajan, Lisa Saiman
Dec 14, 2002·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonUNKNOWN Cystic Fibrosis Therapeutics Development Network Study Group
Aug 16, 2005·Chest·Miguel Angel Martínez-GarcíaJuan José Soler-Cataluña
Jan 7, 2006·The Journal of Antimicrobial Chemotherapy·F RatjenH Grasemann
May 3, 2006·Respiratory Medicine·Paul T KingPeter W Holmes
Jun 30, 2006·The European Respiratory Journal·S J FowlerD Bilton
Jul 29, 2008·American Journal of Respiratory and Critical Care Medicine·Karen S McCoyA Bruce Montgomery
Nov 11, 2008·International Archives of Medicine·Henrique Douglas M CoutinhoGregório Fernandes Gonçalves
Apr 10, 2009·The European Respiratory Journal·M R LoebingerR Wilson
Sep 28, 2010·American Journal of Respiratory and Critical Care Medicine·Maeve P MurrayAdam T Hill
Oct 22, 2011·QJM : Monthly Journal of the Association of Physicians·K L M HesterA De Soyza
May 1, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Casilda OlveiraFrancisco Espildora
Jun 30, 2012·American Journal of Respiratory and Critical Care Medicine·James D ChalmersAdam T Hill
Sep 29, 2012·The European Respiratory Journal·Robert WilsonBarbara Hampel
Aug 1, 2013·American Journal of Respiratory and Critical Care Medicine·Pamela J McShaneMary E Strek
Oct 22, 2013·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Casilda OlveiraMiguel-Angel Martinez-Garcia
Mar 15, 2014·American Journal of Respiratory and Critical Care Medicine·Charles S HaworthDiana Bilton
Oct 3, 2014·Archives of Medical Science : AMS·Haiqing ChuXiwen Sun
Jun 27, 2015·Journal of Immunology Research·Paul T King, Roleen Sharma
Sep 6, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M C AlaninH K Johansen
Jun 21, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yong-Hua GaoGuo-Jun Zhang
Jan 19, 2018·Annals of the American Thoracic Society·Mark L MeterskyDavid Mannino
Feb 2, 2018·The European Respiratory Journal·David AraújoJames D Chalmers
Feb 2, 2018·The European Respiratory Journal·Miguel Angel Martinez-García

❮ Previous
Next ❯

Citations

Apr 6, 2021·International Journal of Nanomedicine·Alanood S AlmurshediAmany Z Mohamoud
May 20, 2019·Respiration; International Review of Thoracic Diseases·Letizia TraversiEva Polverino

❮ Previous
Next ❯

Software Mentioned

RESPIRE

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.